Reaction

Pustule reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,271 reports · 63 co-occurring drugs

As of the last recalculation, Pustule appears in 2,271 FAERS reports alongside 63 co-occurring drug terms. The strongest observed disproportionality signal is PANITUMUMAB (PRR 29.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Panitumumab	50	29.9	30.0
Terbinafine Hydrochloride	28	29.2	29.3
Ketoconazole Foam	24	15.0	15.1
Ketoconazole Cream, 2%	24	15.0	15.0
Minocycline	18	14.3	14.3
Ketoconazole	25	13.4	13.4
Clindamycin Phosphate	44	12.3	12.3
Clindamycin	36	11.8	11.8
Clobetasol Propionate	13	11.6	11.6
Infliximab-Dyyb	36	11.5	11.5
Secukinumab	186	11.4	11.4
Mupirocin	16	10.9	11.0
Mupirocin Calcium	16	10.7	10.7
Tofacitinib Citrate	14	9.8	9.9
Clobetasol Propionate Ointment Usp, 0.05%	11	9.8	9.8
Dapsone	11	9.5	9.5
Mometasone	18	9.1	9.1
Trimethoprim	11	8.6	8.6
Daspone	9	8.5	8.5
Dapsone Gel, 5%	9	8.5	8.5
Piperacillin Sodium,Tazobactam Sodium	23	8.0	8.0
Adalimumab-Aaty	40	7.9	7.9
Adalimumab-Fkjp	39	7.8	7.8
Doxycycline Hyclate	56	7.8	7.8
Doxycycline	56	7.7	7.7
Adalimumab-Adaz	43	7.6	7.6
Isotretinoin	39	7.3	7.3
Exemestane	16	6.9	6.9
Fondaparinux Sodium	6	6.8	6.8
Tretinoin	6	6.8	6.8
Midazolam	18	6.6	6.6
Midazolam Hydrochloride	19	6.5	6.5
Nemolizumab-Ilto	9	6.5	6.5
Encorafenib	7	6.5	6.5
Bimekizumab	15	6.5	6.5
Piperacillin And Tazobactam	9	6.5	6.5
Upadacitinib	55	6.3	6.3
Dextrose	9	6.3	6.3
Dextrose Monohydrate	9	6.2	6.2
Doxyclycline Hyclate	11	5.9	5.9
Triamcinolone Acetonide Ointment Usp, 0.05%	15	5.9	5.9
Ixekizumab	23	5.7	5.7
Gefitinib	5	5.1	5.1
Dupilumab	242	5.0	5.0
Cetuximab	16	4.7	4.7
Osimertinib	16	4.6	4.6
Risankizumab-Rzaa	38	4.3	4.3
Trametinib	11	4.2	4.2
Pertuzumab	12	4.1	4.1
Trastuzumab	30	4.0	4.0
Botulinum Toxin Type A	5	3.7	3.7
Guselkumab	14	3.6	3.6
Irinotecan Hydrochloride	5	3.6	3.6
Vibegron	3	3.4	3.4
Ustekinumab	33	3.0	3.0
Crisaborole	3	2.9	2.9
Cabozantinib	13	2.5	2.5
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	8	2.4	2.4
Apalutamide	3	2.3	2.3
Salicylic Acid	12	2.1	2.1
Aflibercept	6	1.8	1.8
Adapalene	34	1.7	1.7
Apremilast	19	1.2	1.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.